SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Implantable device could limit seizures

Wednesday February 15th 2023

New implantable devices have been developed to monitor the brain for epileptic seizures, researchers in Glasgow have announced.

The implantable ‘microbots’ are made of advanced nanomaterials a fraction of a millimetre in size, and controlled by a small, wearable control unit.

The wearer can monitor its electrical activity and detect the onset of a seizure, which can be limited using targeted neurostimulation.

Professor Hadi Heidari, of the University of Glasgow, UK, is contributing to the 'CROSSBRAIN' project.

He said: “We’re pleased to be part of this ambitious project, which has the potential to pave the way for transformative treatments for pathological brain conditions like epilepsy.

“CROSSBRAIN brings together leading researchers from across Europe, with a wide range of expertise in bioengineering, artificial intelligence, nanomaterial design and fabrication, and medical physics.

"I’m looking forward to collaborating with my colleagues to develop this exciting technology in the years to come.”

The microbots will be developed further over the next four years, allowing them to deliver genetic material on command, in addition to the cell- and microcircuit-level neuromodulation.

Principal investigator on the project is Professor Nicola Toschi at the Tor Vergata University of Rome, Italy.

“Within brain tissue, neurons communicate through a complex interplay of signalling mechanisms, including chemical, thermal, and electrical (depolarisation / repolarisation) changes," he said.

"It is widely known that many pathological brain conditions directly involve aberrant electrical activity of the brain, such as epileptic seizures or panic disorders.

"In such conditions, timely recognition and prompt intervention are essential to begin effective periodic and adaptive treatment.

"However, the technologies available to guide and modulate brain activity in a precise and selective way for therapeutic purposes are severely limited to date.

"Innovation in the field of nanomaterials provides the opportunity to modulate neuronal activity with greater precision and sensitivity."

Tags: Brain & Neurology | UK News

Printer friendly page Printer friendly page

CATEGORIES